117 related articles for article (PubMed ID: 16683526)
21. [Anticancer effects of Pingyangmycin-activated carbon nanoparticles against human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in vitro].
Sun ML; Wang CM; Wen YM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2010 Jun; 28(3):257-60. PubMed ID: 20635652
[TBL] [Abstract][Full Text] [Related]
22. [Antitumor effect of the immunoconjugate composed of antibiotic C1027 and Fab fragment from a monoclonal antibody directed against human hepatoma].
Li JZ; Jiang M; Xue YC; Zhen YS
Yao Xue Xue Bao; 1993; 28(4):260-5. PubMed ID: 8213168
[TBL] [Abstract][Full Text] [Related]
23. [Experimental study of combined target treatments using PYM-BAC5 and 131I-BAC5 to nasopharyngeal carcinoma].
Liang ZP; Liu CZ; Cheng JY; Xiao XB; Zhang CQ; Liang CS
Ai Zheng; 2003 Aug; 22(8):831-5. PubMed ID: 12917029
[TBL] [Abstract][Full Text] [Related]
24. Identification of carbonic anhydrase 9 as a contributor to pingyangmycin-induced drug resistance in human tongue cancer cells.
Zheng G; Zhou M; Ou X; Peng B; Yu Y; Kong F; Ouyang Y; He Z
FEBS J; 2010 Nov; 277(21):4506-18. PubMed ID: 21040473
[TBL] [Abstract][Full Text] [Related]
25. [Experimental studies on the antitumor activity of monoclonal antibody--bleomycin A6 conjugate against human liver cancer].
Peng Z; Zhen YS
Yao Xue Xue Bao; 1991; 26(5):331-5. PubMed ID: 1720270
[TBL] [Abstract][Full Text] [Related]
26. [Anticancer spectrum of pingyangmycin in vitro].
Li XT
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):182-6. PubMed ID: 1706647
[TBL] [Abstract][Full Text] [Related]
27. [Preparation of lymphatic targeting dosage form: pingyangmycin absorbed on activated carbon nanoparticles].
Sun ML; Wen YM; Wang CM; Li LJ; Wang XY
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Jun; 22(3):183-5. PubMed ID: 15293458
[TBL] [Abstract][Full Text] [Related]
28. [Effect of pingyangmycin on the growth and cell cycle of human vascular endothelial cells].
Kong WD; Li YH; Zeng QL; Chen Y; He XF
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):830-2, 836. PubMed ID: 12919911
[TBL] [Abstract][Full Text] [Related]
29. Induction of apoptosis in KB cells by pingyangmycin.
Tai KW; Chou MY; Hu CC; Yang JJ; Chang YC
Oral Oncol; 2000 Mar; 36(2):242-7. PubMed ID: 10745179
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
[TBL] [Abstract][Full Text] [Related]
31. Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigen.
Hwang KM; Foon KA; Cheung PH; Pearson JW; Oldham RK
Cancer Res; 1984 Oct; 44(10):4578-86. PubMed ID: 6467213
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of immunoconjugates composed of boanmycin and monoclonal antibody.
Zhen Y; Peng Z; Deng Y; Xu H; Chen Y; Tian P; Li D; Jiang M
Chin Med Sci J; 1994 Jun; 9(2):75-80. PubMed ID: 7528068
[TBL] [Abstract][Full Text] [Related]
33. Neochlorogenic acid enhances the antitumor effects of pingyangmycin via regulating TOP2A.
Che J; Zhao T; Liu W; Chen S; Yang G; Li X; Liu D
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355372
[TBL] [Abstract][Full Text] [Related]
34. Injectable chitosan thermogels for sustained and localized delivery of pingyangmycin in vascular malformations.
Chen F; Song S; Wang H; Zhang W; Lin C; Ma S; Ye T; Zhang L; Yang X; Qin X; Pan W
Int J Pharm; 2014 Dec; 476(1-2):232-40. PubMed ID: 25283699
[TBL] [Abstract][Full Text] [Related]
35. Phosphoinositide 3-kinase/Akt pathway is involved in pingyangmycin‑induced growth inhibition, apoptosis and reduction of invasive potential in EOMA mouse hemangioendothelioma cells.
Peng LX; Zhao P; Zhao HS; Pan E; Yang BB; Li Q
Mol Med Rep; 2015 Dec; 12(6):8275-81. PubMed ID: 26498320
[TBL] [Abstract][Full Text] [Related]
36. [Anti-type IV collagenase single-chain antibody ameliorates bleomycin-induced experimental pulmonary fibrosis in mice].
Lai RY; Miao QF; Li Y; Zhen YS
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1411-5. PubMed ID: 19671337
[TBL] [Abstract][Full Text] [Related]
37. [Experimental study of interstitial chemotherapy with PYM delivered from a solid implantable biodegradable polymer against human tongue SCC in tumor-bearing nude mice].
Chen CJ; Zhang ZY
Shanghai Kou Qiang Yi Xue; 2005 Oct; 14(5):519-24. PubMed ID: 16288335
[TBL] [Abstract][Full Text] [Related]
38. [The effect of ginkgolic acids on multidrug resistance in oral squamous cell carcinoma].
Wang H; Zhou CC; Feng Y; Dai LN; Chen J; Chen SX; Li XY; Liu YR; Zhang P
Hua Xi Kou Qiang Yi Xue Za Zhi; 2010 Dec; 28(6):668-71. PubMed ID: 21365850
[TBL] [Abstract][Full Text] [Related]
39. Disposition of conjugate-bound and free doxorubicin in tumor-bearing mice following administration of a BR96-doxorubicin immunoconjugate (BMS 182248).
Mosure KW; Henderson AJ; Klunk LJ; Knipe JO
Cancer Chemother Pharmacol; 1997; 40(3):251-8. PubMed ID: 9219510
[TBL] [Abstract][Full Text] [Related]
40. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
